Pular para o conteúdo
Merck
Todas as fotos(1)

Documentos Principais

Visualizar Toda a Documentação

PZ0002

Sigma-Aldrich

Maraviroc

≥98% (HPLC)

Sinônimo(s):

4,4-Difluoro-N-[(1S)-3-[(3-exo)-3-[3-methyl-5-(1-methylethyl)-4H-1,2,4-triazol-4-yl]-8-azabicyclo[3.2.1]oct-8-yl]-1-phenylpropyl]cyclohexanecarboxamide, UK-427857

Faça loginpara ver os preços organizacionais e de contrato
Todas as fotos(1)

About This Item

Fórmula empírica (Notação de Hill):
C29H41F2N5O
Número CAS:
376348-65-1
Peso molecular:
513.67
Número MDL:
MFCD13188530
Código UNSPSC:
12352200
ID de substância PubChem:
329823671
NACRES:
NA.77

Nível de qualidade

100

Ensaio

≥98% (HPLC)

Formulário

powder

atividade óptica

[α]-15/D

cor

white

solubilidade

DMSO: >30 mg/mL

temperatura de armazenamento

room temp

cadeia de caracteres SMILES

CC(C)c1nnc(C)n1[C@H]2C[C@@H]3CC[C@H](C2)N3CC[C@H](NC(=O)C4CCC(F)(F)CC4)c5ccccc5

InChI

1S/C29H41F2N5O/c1-19(2)27-34-33-20(3)36(27)25-17-23-9-10-24(18-25)35(23)16-13-26(21-7-5-4-6-8-21)32-28(37)22-11-14-29(30,31)15-12-22/h4-8,19,22-26H,9-18H2,1-3H3,(H,32,37)/t23-,24+,25-,26-/m0/s1

chave InChI

GSNHKUDZZFZSJB-QYOOZWMWSA-N

Informações sobre genes

human ... CCR5(1234)

Aplicação

Maraviroc has been used as a C-C chemokine receptor type 5 (CCR5-specific) inhibitor in murine monocyte/macrophage cell line J774A.1, porcine uterine luminal epithelial cells and human lung CD4+ T cells.

Ações bioquímicas/fisiológicas

Maraviroc is a CCR5 chemokine receptor antagonist, and antiretroviral entry inhibitor. Maraviroc inhibits HIV entry by blocking interaction of viral coat protein gp120 with the receptor.
Maraviroc is metabolised by cytochrome P450 3A4. The transport and absorption of maraviroc in the intestine and bile is regulated by P-glycoprotein (Pgp). Maraviroc binds to the active site pocket of chemokine receptor CCR5 making the receptor inactive.

Características e benefícios

This compound is featured on the Chemokine Receptors page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.

Código de classe de armazenamento

11 - Combustible Solids

Classe de risco de água (WGK)

WGK 1

Ponto de fulgor (°F)

Not applicable

Ponto de fulgor (°C)

Not applicable

Escolha uma das versões mais recentes:

Certificados de análise (COA)

Lot/Batch Number
011M4727V

Não está vendo a versão correta?

Se precisar de uma versão específica, você pode procurar um certificado específico pelo número do lote ou da remessa.

Pesquise por COA

Já possui este produto?

Encontre a documentação dos produtos que você adquiriu recentemente na biblioteca de documentos.

Visite a Biblioteca de Documentos

Os clientes também visualizaram

Slide 1 of 7

1 of 7

Crizotinib ≥98% (HPLC)

Sigma-Aldrich

PZ0191

Crizotinib

Atazanavir ≥98% (HPLC)

Sigma-Aldrich

SML1796

Atazanavir

Efavirenz ≥98% (HPLC)

Sigma-Aldrich

SML0536

Efavirenz

Gefitinib ≥98% (HPLC)

Sigma-Aldrich

SML1657

Gefitinib

Lopinavir ≥98% (HPLC)

Sigma-Aldrich

SML1222

Lopinavir

Gold nanoparticles 5 nm diameter, OD 1, stabilized suspension in citrate buffer

Sigma-Aldrich

741949

Gold nanoparticles

Gelatin solution Type B, 2% in H2O, tissue culture grade, BioReagent, suitable for cell culture

Sigma-Aldrich

G1393

Gelatin solution

HIV-1 and SIV Infection Are Associated with Early Loss of Lung Interstitial CD4+ T Cells and Dissemination of Pulmonary Tuberculosis
Corleis B, et al.
Testing, 26(6), 1409-1418 (2019)
Characterization of CC motif chemokine ligand 4 in the porcine endometrium during the presence of the maternal-fetal interface
Lim W, et al.
Developmental Biology, 441(1), 146-158 (2018)
Structure of the CCR5 chemokine receptor-HIV entry inhibitor maraviroc complex
Tan Q, et al.
Science, 341(6152), 1387-1390 (2013)
Assessment of the absorption, metabolism and absolute bioavailability of maraviroc in healthy male subjects
Abel S, et al.
British Journal of Clinical Pharmacology, 65, 60-67 (2008)
Juan G Sierra-Madero et al.
The lancet. HIV, 1(2), e60-e67 (2015-10-02)
Immune reconstitution inflammatory syndrome (IRIS) is a common complication of antiretroviral therapy (ART) in patients with HIV. IRIS is associated with an increased risk of admission to hospital and death. We assessed whether CCR5 blockade with maraviroc reduces the risk
Exibir todos os documentos relacionados

Artigos

Chemokine Receptors

Sigma-Aldrich offers many products related to chemokine receptors for your research needs.

Conteúdo relacionado

Discover Bioactive Small Molecules for Immunology Research

We offer agonists, antagonists, modulators and other bioactive small molecules for immune system signaling target identification and validation, as well as a variety of antibiotics, antivirals, and antifungals.

Nossa equipe de cientistas tem experiência em todas as áreas de pesquisa, incluindo Life Sciences, ciência de materiais, síntese química, cromatografia, química analítica e muitas outras.

Entre em contato com a assistência técnica